Leslie Merryman

Congratulations to Drs. Michael Jaffee and Steven DeKosky on the publication of “Heterogeneous treatment effects of sodium‐glucose cotransporter 2 inhibitors on risk of dementia in people with type 2 diabetes: A population‐based cohort study,” which appears in the July 2024 issue of Alzheimer’s and Dementia. Abstract INTRODUCTION Sodium‐glucose cotransporter 2…

Congratulations to Drs. Ariane Veilleux Carpentier, Joshua K. Wong and Michael S. Okun on the publication of “An Eye on the First Surgical Side: Appreciating the Potential Impacts of a Second DBS Lead on Ipsilateral Symptoms,” which appears in the recent issue of Tremor and Other Hyperkinetic Movements. Abstract Clinical…

Congratulations to Drs. Joshua Wong, Nikolaus McFarland, and Adlofo Ramierz-Zamora on the publication of “Characterizing Disease Progression inParkinson’s Disease from Videos of the Finger Tapping Test,’ which appears in IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING. Abstract— Introduction: Parkinson’s disease (PD) is characterized by motor symptoms whose progression…

Congratulations to Drs. Joshua Wong, Nikolaus McFarland and Adlofo Rameriez-Zamora on the publication of “Characterizing Disease Progression in Parkinson’s Disease from Videos of the Finger Tapping Test,” which appears in the June issue of IEE Transactions on Neural Systems. Abstract: Introduction: Parkinson’s disease (PD) is characterized by motor symptoms whose…

Congratulations to Drs. Kara Johnson, Adlofo Ramierz-Zamora, Michael Okun and Joshua Wong on the publication of “Editorial: Deep Brain Stimulation Think Tank: Updates in Neurotechnology and Neuromodulation, Volume IV,” which appears as an editorial in Frontiers in Human Neuroscience.

Congratulations to Drs. Irene Malaty and Michael Okun on the publication of “Diagnostic Criteria for Primary Tic Disorders: Time for Reappraisal,” which appears in the June edition of Movement Disorders as a viewpoint article. The Relevance of the ProblemThe most widely applied diagnostic criteria for Tourette syndrome (TS) and…

Alzheimer’s disease is not a normal part of aging. Join us to learn about the impact of Alzheimer’s; the difference between Alzheimer’s and dementia; stages and risk factors; current research and treatments available for some symptoms; and Alzheimer’s Association resources. Program starts July 9th at noon ET/11 a.m. CT. To…

Monday, July 1 | 12:30-1:30 p.m.Alzheimer’s is a global health problem with nearly 7 million people living with the disease in the U.S. alone. Tremendous gains have been made in theunderstanding of the science and basic biology underlying Alzheimer’s and other dementias. These advances are leading to great…

Congratulations Dr. Abbas Babajani-Feremi on the publication of “Seeing beyond the symptoms: biomarkers and brain regions linked to cognitive decline in Alzheimer’s disease,” which appears in the May 15th edition of Frontiers in Aging Neuroscience. Abstract Objective Early Alzheimer’s disease (AD) diagnosis remains challenging, necessitating specific biomarkers for timely detection.

Congratulations to Dr. Steven Dekosky on the publication of “1779-LB: Hospitalization for Hypoglycemia and Its Risk Factors among Patients with Diabetes and Cognitive Impairment,” which appears in the June issue of Diabetes. Abstract Introduction: Hypoglycemia is the most common serious adverse effect of diabetes treatments and a major cause of…